Skip to the questions

Tirzepatide questions you can take along

Tirzepatidecare notes

The longer view

Ask what happens after the first visit.

An offer needs more than a first visit and a delivery. Ask who stays involved, what later care includes and how the plan can change.

Make the contact route clear

FDA flags online care when no doctor with a licence is available to answer questions after the medicine arrives.

  • Who reads a message about a health concern?
  • What is the contact route for the person responsible for my care?
  • What reply time does the service commit to?
  • What care is available when that person is away?

Plan later care and stopping

Request a plan you can describe back to the person treating you. Include changes in your health or your goals, rather than treating each visit as a refill task.

  • What are we checking at later visits?
  • How will we judge progress beyond a scale reading?
  • What changes in my health do you want to hear about?
  • Which visits are included in the quoted fee?

Discuss stopping before it becomes urgent

In the SURMOUNT-4 study, people switched from tirzepatide to a shot without the medicine regained weight. People who continued tirzepatide lost more weight.

A study cannot decide your care plan. Ask the person treating you how to think about stopping, cost changes or a wish to try another approach.

  • What support is available if we decide to stop?
  • What happens if I cannot keep paying?
  • Can I keep copies of my records if I move to another service?
  • Does leaving the care plan also cancel the membership?

Sources for this chapter

Use these sources to check the answers above. Bring any questions to the person treating you.

Keep the question movingName the medicine